ERBB3 and IGF1R Signaling Are Required for Nrf2-Dependent Growth in KEAP1-Mutant Lung Cancer
Steffan Vartanian(Discovery Centre), David Stokoe(Cancer Research Institute)
Cited by 27
Related Papers
Epidermal Growth Factor Receptor, Protein Kinase B/Akt, and Glioma Response to Erlotinib
|JNCI Journal of the National Cancer Institute|2005|467
Activation of c‐Raf‐1 by Ras and Src through different mechanisms: activation in vivo and in vitro
|The EMBO Journal|1997|145